TRIB Trinity Biotech plc

$TRIB FLOAT = 813K Cash: ~$5.14M Total debt: ~$137.98M Net debt: roughly $132.85M TTM free cash flow: about -$6.0M. Active: * $4.35M ATM * Perceptive convertible debt to convert up to $72.5M principal

$TRIB re-appointed its statutory auditor Grant Thornton and director Dr Andrew Omidvar at the AGM.

$TRIB stay far away from this scam. Victim here of two R/S. Promises and more promises of deals and projects but nothing ever happens.

$TRIB Just a note: if you are working with a CGM partner, but the partner has made no financial commitment, and there is no contractual obligation requiring them to do so going forward, it’s not a partnership. You’ve just given them a free call option.

$TRIB Likely this company is sold if Gillard’s promised deals don’t come through. Jeon might yet have his revenge.

$TRIB Market Cap 4m. Isn’t 15m the magic number you need? So 4x the actual price or death incoming soon.

$TRIB Everyone in the investment community knows the scam they are running here. I get an occasional day trade or swing trade but investors know to stay away from this garbage.

$TRIB As to CGM+, the “+” is key. CGM’s which don’t collect data for future model-building will be stone-age at some point. That’s why Dexcom’s cloud is so valuable, even though Dexcom only collects glucose data at this point.

$TRIB Only an idiot will continue to put money in this company. Its a scam. I warned you right before first reverse split to stay away.

$TRIB garage management, no cash on hand. Dilution will start again just like they always do.